Chronicles of A.I. Pospelov Moscow Society of Dermatovenerologists and Cosmetologists (MSDС, founded on October 4, 1891). MSDС Bulletin No. 1163

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

On May 16, 2025, the 1163rd meeting of the A.I. Pospelov Moscow Society of Dermatovenerologists and Cosmetologists was held. The physical meeting was held at the President Hotel (24 Bolshaya Yakimanka Street) as part of the 42nd International Rakhmanov Research-to-Practice Conference. A total of 68 participants attended. Two physicians from private esthetic medicine clinics in Moscow applied for membership in the A.I. Pospelov Moscow Society of Dermatovenerologists and Cosmetologists.

Two reports were presented during the clinical part of the meeting: on polypharmacy-induced toxic epidermal necrolysis and on diagnostic errors in pyoderma gangrenosum. Both reports were presented by researchers from Sechenov University. The first report discussed a clinical case of toxic epidermal necrolysis in a 63-year-old female patient. The condition was likely induced by an antipsychotic agent. During therapy, the patient developed eczema herpeticum. Timely treatment with adequate doses of systemic glucocorticoids and corrective therapy enabled saving the patient’s life. The second report addressed diagnostic challenges in pyoderma gangrenosum. To effectively treat ulcerative pyoderma gangrenosum in a 57-year-old patient, prednisolone therapy in combination with azathioprine and fluconazole was used.

The scientific part of the meeting began with a report on the potential applications of intense pulsed light (IPL) therapy. According to the reporter’s extensive clinical experience, IPL therapy is beneficial in the majority of cases, despite differences in the pathogenesis of skin inflammation in various disorders.

Furthermore, a report on the advantages of 595 nm yellow dye laser in the treatment of warts, including recurrent ones, was presented. The development of cosmeceuticals under the Dr. Sechenov brand for the prevention of vitiligo and atopic dermatitis was discussed, considering the consistently high prevalence of autoimmune diseases in Russia.

Keywords

About the authors

Alexey B. Yakovlev

Central State Medical Academy of Department of Presidential Affairs

Author for correspondence.
Email: rjdv@eco-vector.com
ORCID iD: 0000-0001-7073-9511
Russian Federation, Moscow

Ivan S. Maximov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: rjdv@eco-vector.com
ORCID iD: 0000-0003-2850-2910
Russian Federation, Moscow

References

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. MSDC meeting № 1163 is being held in the conference hall of the President Hotel.

Download (1MB)
3. Fig. 2. In the Presidium of the MSDC № 1163 meeting: Associate Professor of the Department of Dermatovenerology and Cosmetology of the Central State Medical Academy of the Russian Presidential Administration, PhD, A.B. Yakovlev.

Download (359KB)
4. Fig. 3. Report by E.A. Morozova, PhD, Assistant Professor at the V.A. Rakhmanov Department of Skin and Venereal Diseases, Sechenov University.

Download (867KB)
5. Fig. 4. Report by O.Y. Luchenkova, dermatovenerologist, cosmetologist, Galaktika Clinic.

Download (976KB)

Copyright (c) 2025 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).